Boston Scientific (BSX) Share-based Compensation (2009 - 2026)

Boston Scientific has disclosed Share-based Compensation across 18 years of filings, most recently posting $83.0 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $83.0 million, up 12.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $308.0 million (up 11.19% YoY), and the FY2025 annual result was $299.0 million, up 12.41% from the prior year.
• Share-based Compensation came in at $83.0 million for Q1 2026 at Boston Scientific, up from $71.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $83.0 million in Q1 2026 to a low of $52.0 million in Q1 2022.
• The 5-year median for Share-based Compensation is $63.0 million (2024), against an average of $64.8 million.
• Across the five-year window, Share-based Compensation gained 1.72% in 2023 and increased 17.46% in 2025, its largest moves.
• Boston Scientific's Share-based Compensation stood at $55.0 million in 2022, then climbed by 7.27% to $59.0 million in 2023, then gained by 16.95% to $69.0 million in 2024, then increased by 2.9% to $71.0 million in 2025, then grew by 16.9% to $83.0 million in 2026.
• The last three Share-based Compensation figures came in at $83.0 million (Q1 2026), $71.0 million (Q4 2025), and $79.0 million (Q3 2025), per Business Quant data.